| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| Alight (ALIT) | BofA Merrill Lynch, J.P. Morgan / Morgan Stanley | $100.00 | n.a. | |||
| Crescent Acquisition (CRSAU) (u) | Credit Suisse/ BofA Merrill Lynch | 25.00 | $10.00 | $10.00 | $250.00 | n.a. |
| Hennessy Capital Acquisition (HCACU) | Nomura/ Stifel | 25.00 | $10.00 | $10.00 | $250.00 | n.a. |
| Levi Strauss (LEVI) | Goldman Sachs/ J.P. Morgan | $100.00 | n.a. | |||
| Tuscan Holdings (THCBU) (u) | EarlyBirdCapital | 20.00 | $10.00 | $10.00 | $200.00 | n.a. |
| u – unit offering | $900.00 | n.a. | ||||
| n.a. (not available) | ||||||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| None | ||||||
| New Terms | ||||||
| Acamar Partners Acquisition (ACAMU) (u) | Goldman Sachs/ Deutsche Bank Securities | 30.00 | $10.00 | $10.00 | $300.00 | S/O |
| Super League Gaming (SLGG) | Northland Capital/ Markets Lake Street | 2.27 | $10.00 | $12.00 | $25.00 | S/O |
| S/O (Subscribers Only) | ||||||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of Feb. 4, 2019 | Manager(s) | Offered | Raised | Price | 2/8/19 | Change |
| Hoth Therapeutics (HOTH) | Laidlaw & Company (UK) Ltd. | 1.25 | $7.00 | $5.60 | $8.53 | 52.32% |
| TCR2 Therapeutic (TCRR) | Jefferies/ Leerink Partners/ BMO Capital Markets | 1.70 | $25.50 | $15.00 | $15.01 | 0.07% |
| IMAC Holdings (IMACW) | Dawson James Securities/ Cuttone | 1.70 | $0.00 | $0.00 | $0.60 | 0 |
| Stealth BioTherapeutics (MITO) | Jefferies/ Evercore ISI/ BMO Capital Markets | 6.50 | $78.00 | $12.00 | $11.90 | -0.83% |
| Avedro (AVDR) | BofA Merrill Lynch/ J.P. Morgan | 0.85 | $11.90 | $14.00 | $12.35 | -11.79% |
| IMAC Holdings (IMAC) | Dawson James Securities/ Cuttone | 0.85 | $4.25 | $5.00 | $3.82 | -23.60% |
